홈 > 시장보고서 > 의료기기 > 체외진단

시장보고서

상품코드

1720556

세계의 길랭 바레 증후군(GBS) 진단 시장 : 시장 규모, 점유율, 동향, 산업 분석 : 검사별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)

Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test, End Use, and Region - Market Forecast, 2025-2034

발행일: 2025년 04월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 125 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 길랭 바레 증후군(GBS) 진단 시장 규모는 2034년까지 1억 9,071만 달러에 달할 것으로 예측됩니다.

길랭 바레 증후군(GBS)의 진단은 말초신경계에 영향을 미치는 희귀한 자가면역질환의 존재를 확인하기 위해 임상적 평가와 신경전도 검사, 요추 천자 등의 검사를 병행하여 시행합니다.

의료 진단의 기술적 진보가 GBS 진단 시장의 성장을 가속하고 있습니다. 고해상도 신경전도 검사와 개선된 요추 천자 등 보다 새롭고 정교한 도구를 통해 의료진은 이전보다 더 정확하고 신속하게 GBS를 진단할 수 있게 되었습니다. 이러한 발전은 오진 가능성을 줄이고, 치료 지연으로 인한 환자의 상태 악화를 줄일 수 있게 되었습니다. 또한, 혁신적인 진단 플랫폼은 환자와 의료진 모두에게 비침습적이고 보다 빠르고 저렴한 비침습적 옵션을 제공하여 GBS의 효과적인 식별과 치료를 용이하게 하고 있습니다. 이러한 지속적인 기술 혁신은 길랭 바레 증후군(GBS) 진단 시장의 성장을 가속하고 있습니다.

의학 연구에 대한 자금 지원 증가는 길랭 바레 증후군(GBS) 진단 시장 동향에 큰 영향을 미치고 있습니다. 정부, 민간단체, 의료기관은 길랭 바레 증후군(GBS) 및 그 원인 연구, 진단 효율성 향상에 더 많은 자원을 투자하고 있습니다. 이러한 투자를 통해 진단의 정확도를 높이고 진단 시간을 단축하는 새로운 방법, 도구, 기술이 개발되고 있습니다. 또한, 연구 자금 지원은 GBS에 대한 이해를 높이고, 보다 효과적인 진단 전략으로 이어지고 있으며, GBS 연구에 대한 자금 지원은 첨단 진단 솔루션의 가용성을 지속적으로 촉진하여 조기 발견과 치료가 환자들에게 더 가까이 다가갈 수 있도록 돕고 있습니다.

길랭 바레 증후군(GBS) 진단 시장 보고서의 주요 내용

최종 용도별로는 병원 및 클리닉 부문이 GBS 진단에 필요한 자원을 이용할 수 있기 때문에 2024년 길랭 바레 증후군(GBS) 진단 시장 점유율을 차지할 것으로 예측됩니다.

검사별로는 뇌척수액의 단백질 농도 상승을 분석하여 GBS 진단에 도움이 되는 중요한 검사로 요추 천자 부문이 예측 기간 동안 가장 빠르게 성장할 것으로 예측됩니다.

2024년 북미가 GBS 진단 시장의 매출 점유율을 독점했습니다. 이는 선진화된 의료 인프라와 희귀질환에 대한 높은 인지도에 기인합니다.

아시아태평양은 의료 인프라 개선과 희귀질환에 대한 인식이 높아지면서 예측 기간 동안 큰 점유율을 기록할 것으로 예측됩니다.

세계 주요 시장 기업으로는 Alpine Biomed,Bionen Medical Devices,Cadwell Industries, Inc,Deymed Diagnostic,EMS Biomedical,Medtronic plc,Natus Medical Incorporated, Neurosoft, Nihon Kohden Corporation, Rochester Electro-Medical, Inc. 등이 있습니다.

이 보고서는 세계 길랭 바레 증후군(GBS) 진단 시장에 대해 조사했으며, 현재 시장 역학에 대한 상세한 고찰과 향후 시장 성장에 대한 분석을 제공합니다.

주요 조사 결과
서론
- 길랭 바레 증후군(GBS) 진단 시장 분석 : 지역별(2020년-2034년)
북미
- 북미 : 검사별(2020년-2034년)
- 북미 : 최종 용도별(2020년-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 검사별(2020년-2034년)
- 유럽 : 최종 용도별(2020년-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 검사별(2020년-2034년)
- 아시아태평양 : 최종 용도별(2020년-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 검사별(2020년-2034년)
- 중동 및 아프리카 : 최종 용도별(2020년-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 검사별(2020년-2034년)
- 라틴아메리카 : 최종 용도별(2020년-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제8장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
파트너십/협업/합의/공개

제9장 기업 개요

Alpine Biomed
Bionen Medical Devices
Cadwell Industries, Inc
Deymed Diagnostic
EMS Biomedical
Medtronic plc
Natus Medical Incorporated
Neurosoft
Nihon Kohden Corporation
Rochester Electro-Medical, Inc.

LSH 25.05.22

The Guillain-Barre syndrome (GBS) diagnostics market size is expected to reach USD 190.71 million by 2034, according to a new study by Polaris Market Research. The report "Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test (Lumber Puncture, Nerve Conduction, Electromyography, and Others), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Guillain-Barre Syndrome (GBS) diagnostics involves a combination of clinical evaluation and tests such as nerve conduction studies and lumbar puncture to confirm the presence of this rare autoimmune disorder affecting the peripheral nervous system.

Technological advancements in medical diagnostics are driving the GBS diagnostics market growth. Newer, more sophisticated tools such as high-resolution nerve conduction studies and improved lumbar punctures allow healthcare professionals to diagnose GBS more accurately and faster than before. These developments have reduced the chances of misdiagnosis, which delay treatment and worsen the patient's condition. Moreover, innovative diagnostic platforms now offer noninvasive, quicker, and more affordable options for both patients and healthcare providers, making it easier to identify and treat GBS effectively. These ongoing innovations are driving the Guillain-Barre syndrome diagnostics market expansion.

Increasing funding for medical research has significantly impacted the Guillain-Barre Syndrome diagnostics market trends. Governments, private organizations, and healthcare institutions are investing more resources into studying GBS, its causes, and improving diagnostic efficiency. These investments have led to the development of new methods, tools, and technologies that improve accuracy and reduce diagnosis time. Research funding has also deepened the understanding of the disease, leading to more effective detection strategies. Financial support for GBS research continues to drive the availability of advanced diagnostic solutions, making early detection and treatment more accessible to patients.

Guillain-Barre Syndrome Diagnostics Market Report Highlights

Based on end use, the hospital and clinics segment dominated the Guillain-Barre syndrome diagnostics market share in 2024 due to the availability of the required resources for the diagnosis of GBS.

The lumber puncture segment, by test, is expected to witness the fastest growth during the forecast period as it is a critical test that helps diagnose GBS by analyzing the cerebrospinal fluid for elevated protein levels.

In 2024, North America dominated the GBS diagnostics market revenue share, driven by advanced healthcare infrastructure and high awareness of rare diseases.

Asia Pacific is expected to record a significant share during the forecast period, due to improving healthcare infrastructure and increasing awareness of rare diseases.

A few global key market players are Alpine Biomed; Bionen Medical Devices; Cadwell Industries, Inc; Deymed Diagnostic; EMS Biomedical; Medtronic plc; Natus Medical Incorporated; Neurosoft; Nihon Kohden Corporation; and Rochester Electro-Medical, Inc.

Polaris Market Research has segmented the Guillain-Barre syndrome diagnostics market report on the basis of test, end use, and region:

By Test (Revenue - USD Million, 2020-2034)

Lumbar Puncture
Nerve Conduction
Electromyography
Other

By End Use (Revenue - USD Million, 2020-2034)

Hospitals and Clinics
Diagnostic Laboratories
Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Guillain-Barre Syndrome Diagnostics Market Insights

4.1. Guillain-Barre Syndrome Diagnostics Market - Market Snapshot
4.2. Guillain-Barre Syndrome Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Geriatric Population
  - 4.2.1.2. Rising Prevalence of Guillain-Barre Syndrome
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of Skilled Workforce
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Guillain-Barre Syndrome Diagnostics Market End Use Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Guillain-Barre Syndrome Diagnostics Market, by Test

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
5.3. Lumbar Puncture
- 5.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Lumbar Puncture, by Region, 2020-2034 (USD Million)
5.4. Nerve Conduction
- 5.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Nerve Conduction, by Region, 2020-2034 (USD Million)
5.5. Electromyography
- 5.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Electromyography, by Region, 2020-2034 (USD Million)
5.6. Other
- 5.6.1. Global Guillain-Barre Syndrome Diagnostics Market, by Other, by Region, 2020-2034 (USD Million)

6. Global Guillain-Barre Syndrome Diagnostics Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
6.3. Hospitals and Clinics
- 6.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Million)
6.4. Diagnostic Laboratories
- 6.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
6.5. Others
- 6.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Guillain-Barre Syndrome Diagnostics Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Guillain-Barre Syndrome Diagnostics Market Assessment, By Geography, 2020-2034 (USD Million)
7.3. Guillain-Barre Syndrome Diagnostics Market - North America
- 7.3.1. North America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
- 7.3.2. North America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.3.3. Guillain-Barre Syndrome Diagnostics Market - U.S.
  - 7.3.3.1. U.S.: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.3.3.2. U.S.: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.3.4. Guillain-Barre Syndrome Diagnostics Market - Canada
  - 7.3.4.1. Canada: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.3.4.2. Canada: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
7.4. Guillain-Barre Syndrome Diagnostics Market - Europe
- 7.4.1. Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
- 7.4.2. Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.3. Guillain-Barre Syndrome Diagnostics Market - UK
  - 7.4.3.1. UK: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.3.2. UK: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.4. Guillain-Barre Syndrome Diagnostics Market - France
  - 7.4.4.1. France: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.4.2. France: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.5. Guillain-Barre Syndrome Diagnostics Market - Germany
  - 7.4.5.1. Germany: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.5.2. Germany: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.6. Guillain-Barre Syndrome Diagnostics Market - Italy
  - 7.4.6.1. Italy: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.6.2. Italy: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.7. Guillain-Barre Syndrome Diagnostics Market - Spain
  - 7.4.7.1. Spain: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.7.2. Spain: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.8. Guillain-Barre Syndrome Diagnostics Market - Netherlands
  - 7.4.8.1. Netherlands: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.8.2. Netherlands: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.9. Guillain-Barre Syndrome Diagnostics Market - Russia
  - 7.4.9.1. Russia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.9.2. Russia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.10. Guillain-Barre Syndrome Diagnostics Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.10.2. Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
7.5. Guillain-Barre Syndrome Diagnostics Market - Asia Pacific
- 7.5.1. Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
- 7.5.2. Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.3. Guillain-Barre Syndrome Diagnostics Market - China
  - 7.5.3.1. China: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.3.2. China: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.4. Guillain-Barre Syndrome Diagnostics Market - India
  - 7.5.4.1. India: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.4.2. India: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.5. Guillain-Barre Syndrome Diagnostics Market - Malaysia
  - 7.5.5.1. Malaysia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.5.2. Malaysia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.6. Guillain-Barre Syndrome Diagnostics Market - Japan
  - 7.5.6.1. Japan: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.6.2. Japan: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.7. Guillain-Barre Syndrome Diagnostics Market - Indonesia
  - 7.5.7.1. Indonesia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.7.2. Indonesia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.8. Guillain-Barre Syndrome Diagnostics Market - South Korea
  - 7.5.8.1. South Korea: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.8.2. South Korea: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.9. Guillain-Barre Syndrome Diagnostics Market - Australia
  - 7.5.9.1. Australia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.9.2. Australia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.10. Guillain-Barre Syndrome Diagnostics Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.10.2. Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
7.6. Guillain-Barre Syndrome Diagnostics Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
- 7.6.2. Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.6.3. Guillain-Barre Syndrome Diagnostics Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.6.3.2. Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.6.4. Guillain-Barre Syndrome Diagnostics Market - UAE
  - 7.6.4.1. UAE: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.6.4.2. UAE: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.6.5. Guillain-Barre Syndrome Diagnostics Market - Israel
  - 7.6.5.1. Israel: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.6.5.2. Israel: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.6.6. Guillain-Barre Syndrome Diagnostics Market - South Africa
  - 7.6.6.1. South Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.6.6.2. South Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.6.7. Guillain-Barre Syndrome Diagnostics Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.6.7.2. Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
7.7. Guillain-Barre Syndrome Diagnostics Market - Latin America
- 7.7.1. Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
- 7.7.2. Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.7.3. Guillain-Barre Syndrome Diagnostics Market - Mexico
  - 7.7.3.1. Mexico: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.7.3.2. Mexico: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.7.4. Guillain-Barre Syndrome Diagnostics Market - Brazil
  - 7.7.4.1. Brazil: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.7.4.2. Brazil: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.7.5. Guillain-Barre Syndrome Diagnostics Market - Argentina
  - 7.7.5.1. Argentina: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.7.5.2. Argentina: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.7.6. Guillain-Barre Syndrome Diagnostics Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.7.6.2. Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Alpine Biomed
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Bionen Medical Devices
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Cadwell Industries, Inc
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Deymed Diagnostic
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. EMS Biomedical
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Medtronic plc
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Natus Medical Incorporated
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Neurosoft
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Nihon Kohden Corporation
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Rochester Electro-Medical, Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,250

￦ 5,936,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250

￦ 7,333,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250

￦ 8,730,000

※ 부가세 별도

세계의 길랭 바레 증후군(GBS) 진단 시장 : 시장 규모, 점유율, 동향, 산업 분석 : 검사별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)

Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test, End Use, and Region - Market Forecast, 2025-2034

길랭 바레 증후군(GBS) 진단 시장 보고서의 주요 내용

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 길랭 바레 증후군(GBS) 진단 시장 인사이트

제5장 세계의 길랭 바레 증후군(GBS) 진단 시장 : 검사별

제6장 세계의 길랭 바레 증후군(GBS) 진단 시장 : 최종 용도별

제7장 세계의 길랭 바레 증후군(GBS) 진단 시장 : 지역별